TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 23 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,217,315 | +202.0% | 26,500,000 | +278.6% | 0.72% | +184.9% |
Q2 2023 | $5,700,520 | +27064.7% | 7,000,000 | -67.3% | 0.25% | -67.5% |
Q1 2023 | $20,985 | +128.6% | 21,382,000 | +112.1% | 0.77% | +205.1% |
Q4 2022 | $9,181 | -99.9% | 10,082,000 | -32.8% | 0.25% | +17.7% |
Q3 2022 | $15,310,000 | -19.5% | 15,000,000 | -21.1% | 0.22% | -50.3% |
Q2 2022 | $19,009,000 | -4.8% | 19,000,000 | 0.0% | 0.43% | -6.9% |
Q1 2022 | $19,967,000 | – | 19,000,000 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 45,000,000 | $474,089,000 | 9.50% |
ABSOLUTE INVESTMENT ADVISERS, LLC | 4,000,000 | $4,280,000 | 0.96% |
DeepCurrents Investment Group LLC | 22,150,000 | $23,650,000 | 0.74% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 19,000,000 | $19,967,000 | 0.46% |
Context Capital Management, LLC | 5,750 | $6,138,000 | 0.40% |
WOLVERINE ASSET MANAGEMENT LLC | 34,000,000 | $36,271,000 | 0.35% |
Polar Asset Management Partners Inc. | 15,000,000 | $15,993,000 | 0.17% |
LINDEN ADVISORS LP | 20,000,000 | $21,281,000 | 0.13% |
Wellesley Asset Management | 1,599 | $1,599,000 | 0.11% |
Verition Fund Management LLC | 6,213,000 | $6,614,000 | 0.08% |